A Study of CodaLytic, an Intratumoral Oncolytic Virus, in Patients With Breast Cancer
Clinical trial NCT05600582 · WITHDRAWN
Trial details
- NCT number
- NCT05600582
- Sponsor
- Codagenix, Inc
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-15
- Primary completion
- 2024-09-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.